FineHeart, a Bordeaux, France-based medical device company focused on innovative technologies in the cardiovascular space, raised €6.41m in Series A financing.
The round was led by Broadview Ventures, with participation from M Capital Partners, Sofimac, Galia Gestion, IRDInov, and Aqui invest.
The company intends to use the funds to finance the development of its first product.
Founded by Dr. Stéphane Garrigue (ICOMS Inventor) and Dr. Philippe Ritter, co-inventor of cardiac resynchronization therapy, and Arnaud Mascarell, CEO, and Philippe Plas, FineHeart has developed patented ICOMS (Implantable Cardiac Output Management System), a novel, wirelessly powered, fully implantable mechanical circulatory support device that is able to optimize cardiac output while preserving the heart’s innate contractility.
FinSMEs
22/03/2016